Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

May 24, 2022 by Alan Khadavi

Dupixent for EoE (Eosinophilic Esophagitis); FDA approved and New Dosing

Dupixent for EoE (eosinophilic esophagitis) was recently approved by the FDA. This will be the first drug officially approved for EoE.

Eosinophilic Esophagitis is a chronic inflammatory immune disorder of the esophagus where eosinophils (a type of white blood cell) builds up in the esophagus. This can cause symptoms of difficulty swallowing, eating or food getting stuck in the esophagus. Besides the clinical symptoms, EoE is diagnosed during an endoscopy and on microscopic examination, there are more than 15 eosinophils/hpf on esophageal biopsy.

Until now, the treatment for EoE has been off label use of certain medications and avoidance of certain foods that may trigger EoE.

Dupixent is a medication that inhibits a part of the immune pathway (IL-4 and IL-13) that trigger allergic inflammation. This is the 4th allergic indication for Dupixent. Dupixent is also currently approved for Atopic Dermatitis (eczema), Nasal Polyps, and Asthma.

Dupilumab (Dupixent) for Atopic Dermatitis (Eczema) Sufferers

Dupilumab for Nasal Polyps

Dupilumab for Asthma, a New Indication

The dosing of Dupixent for EoE will be different than all the other indications. Dupixent will be dosed 300mg every week, without any loading dose. This is different than the 3 other indications:

Dupixent for Eczema: 600mg loading dose then 300mg every other week

Dupixent for Nasal Polys: No loading dose, 300mg every other week

Dupixent for Asthma: 600mg loading dose, then 300mg every other week

Dupixent for EoE: No loading dose, 300mg every week

*The above dosing is for adults only, Dupixent for EoE dosing is for ages 12 and up, weighing at least 88 pounds. There is a pediatric dosing indication for Dupixent using a 200mg syringe starting at age 6 years old but it is not for EoE as of May 2022. Studies are ongoing for a pediatric indication for EoE.

Dupixent Pediatric Dosing

There are several other drugs seeking FDA approval for EoE as discussed below.

New Eosinophilic Esophagitis Treatments

Eohilia Budesonide Oral Suspension for Eosinophilic Esophagitis

Future Eosinophilic Esophagitis Treatment Options

Eosinophilic Esophagitis Diet

Eosinophilic Esophagitis in Southern California

Other Conditions in Eosinophilic Esophagitis

Risk Factors for Eosinophilic Esophagitis

If you currently suffer from EoE or suspect you may have EoE, it is important that your care is coordinated with a GI (gastroenterologist) and an allergy doctor who can best manage your symptoms and come up with a good treatment plan that is right for you.

Update January 22, 2023

Current active clinical phase 3 trials for EoE for biologics include:

  1. Dupixent for the ages of 1-11.
  2. Benralizumab (Fasenra)
  3. Cendakimab targets anti-IL 13. Early studies have been encouraging meeting their primary endpoints, clinically and histologically. Studies are ongoing. This drug currently has no approved indications
  4. Lirentelimab is an antibody against the Siglec-8 receptor found on eosinophils and mast cells. This drug currently has no approved indications

The US FDA has granted Orphan Drug Designation to benralizumab for the treatment of EoE and a phase 3 clinical study is on-going.

Filed Under: biologics, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page